BBA
ALNY icon

Baker Bros. Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Baker Bros. Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,340
Closed -$425K – 122
2016
Q4 		$425K Hold
11,340
– – ﹤0.01% 122
2016
Q3 		$769K Hold
11,340
– – 0.01% 118
2016
Q2 		$629K Hold
11,340
– – 0.01% 122
2016
Q1 		$712K Hold
11,340
– – 0.01% 122
2015
Q4 		$1.07M Hold
11,340
– – 0.01% 118
2015
Q3 		$911K Hold
11,340
– – 0.01% 120
2015
Q2 		$1.36M Hold
11,340
– – 0.01% 114
2015
Q1 		$1.18M Sell
11,340
-260
-2% -$26.3K 0.01% 118
2014
Q4 		$1.13M Hold
11,600
– – 0.01% 111
2014
Q3 		$906K Hold
11,600
– – 0.01% 99
2014
Q2 		$733K Hold
11,600
– – 0.01% 101
2014
Q1 		$779K Buy
+11,600
New +$898K 0.01% 102

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return